Wall Street is positive on Clearpoint Neuro Inc (CLPT). On average, analysts give Clearpoint Neuro Inc a Strong Buy rating. The average price target is $6, which means analysts expect the stock to lose by -15.49% over the next twelve months.
That average ranking earns Clearpoint Neuro Inc an Analyst Rating of 80, which is better than 80% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Clearpoint Neuro Inc Stock Today?
Clearpoint Neuro Inc (CLPT) stock has risen 7.25% while the S&P 500 is lower by -0.15% as of 3:12 PM on Tuesday, Oct 27. CLPT is higher by $0.48 from the previous closing price of $6.62 on volume of 86,011 shares. Over the past year the S&P 500 has risen 11.73% while CLPT is higher by 70.67%. CLPT lost -$0.43 per share the over the last 12 months.
Click Here to get the full report on Clearpoint Neuro Inc (CLPT) Stock.
